SUBCUTANEOUS MIDAZOLAM, DIAMORPHINE AND HYOSCINE INFUSION IN PALLIATIVE CARE OF A CHILD WITH NEURODEGENERATIVE DISEASE

被引：7
|
作者：
GRIMSHAW, D
HOLROYD, E
ANTHONY, D
HALL, DMB
机构：
[1] SHEFFIELD CHILDRENS HOSP,SHEFFIELD S10 2TH,S YORKSHIRE,ENGLAND
[2] TADWORTH COURT HOSP,TADWORTH,ENGLAND
[3] UNIV SHEFFIELD,SHEFFIELD,S YORKSHIRE,ENGLAND
来源：
CHILD CARE HEALTH AND DEVELOPMENT | 1995年 / 21卷 / 06期
关键词：
PALLIATIVE CARE; NEURODEGENERATIVE DISEASE; MIDAZOLAM;
D O I：
10.1111/j.1365-2214.1995.tb00767.x
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
We report on the use of a subcutaneous infusion of diamorphine, hyoscine and midazolam in the terminal care of a child with a neurodegenerative disease, The technique was safe and effective, and provided good symptom relief including control of previously intractable seizures.
引用
收藏
页码：377 / 381
页数：5
相关论文
共 36 条
  • [21] Physical compatibility and in vivo evaluation of drug mixtures for subcutaneous infusion to cancer patients in palliative care
    Negro, S
    Azuara, ML
    Sánchez, Y
    Reyes, R
    Barcia, E
    SUPPORTIVE CARE IN CANCER, 2002, 10 (01) : 65 - 70
  • [22] Continuous subcutaneous delivery of medications for home care palliative patients—using an infusion set or a pump?
    Sasson Menahem
    Pesach Shvartzman
    Supportive Care in Cancer, 2010, 18 : 1165 - 1170
  • [23] Continuous subcutaneous delivery of medications for home care palliative patients-using an infusion set or a pump?
    Menahem, Sasson
    Shvartzman, Pesach
    SUPPORTIVE CARE IN CANCER, 2010, 18 (09) : 1165 - 1170
  • [24] Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
    Furst, Per
    Lundstrom, Staffan
    Klepstad, Pal
    Strang, Peter
    BMC PALLIATIVE CARE, 2020, 19 (01)
  • [25] Continuous subcutaneous infusion for pain control in dying patients: experiences from a tertiary palliative care center
    Per Fürst
    Staffan Lundström
    Pål Klepstad
    Peter Strang
    BMC Palliative Care, 19
  • [26] Palliative care management of a child with juvenile onset Huntington's disease
    King, Nicola
    INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2005, 11 (06) : 278 - 283
  • [27] Benefits of Early Referral to Pediatric Palliative Care for a Child With a Rare Disease
    Vadeboncoeur, Christina
    McHardy, Mindy
    PEDIATRICS, 2018, 141 (06)
  • [28] Multiple points of system failure underpin continuous subcutaneous infusion safety incidents in palliative care: A mixed methods analysis
    Brown, Amy
    Yardley, Sarah
    Bowers, Ben
    Francis, Sally-Anne
    Bemand-Qureshi, Lucy
    Hellard, Stuart
    Chuter, Antony
    Carson-Stevens, Andrew
    PALLIATIVE MEDICINE, 2025, 39 (01) : 7 - 21
  • [29] Palliative Care Interventions for Persons With Neurodegenerative Disease: A Scoping Review of Clinical Trial Study Design Features
    Ding, Jessica L.
    Ritchie, Christine S.
    Vranceanu, Ana-Maria
    Mace, Ryan A.
    JOURNAL OF PALLIATIVE MEDICINE, 2024, 27 (07) : 939 - 950
  • [30] PHARMACOLOGICAL TREATMENT IN PALLIATIVE CARE. DRUG ADMINISTRATION ROUTE, CONTINUOUS SUBCUTANEOUS INFUSION, ADVERSE SIDE EFFECTS, SYMPTOM MANAGEMENT
    Dominguez Alvarez, Rocio
    Calderon Carrasco, Justo
    Garcia Colchero, Francisco
    Galan Gonzalez-Serna, Jose Maria
    REVISTA ROL DE ENFERMERIA, 2015, 38 (01): : 54 - 63
1234